Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaClear-cell metastatic renal cell carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, clear cell renal carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorderRecruitingPhase 12026-10-05NCT07300241

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Neomorph, Inc1

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
NEO-811 Chicago SiteZionUnited States1
NEO-811 Cleveland SiteClevelandUnited States1
NEO-811 Connecticut SiteNew HavenUnited States1
NEO-811 Dallas SiteDallasUnited States1
NEO-811 Florida SiteMiamiUnited States1
NEO-811 Grand Rapids SiteGrand RapidsUnited States1
NEO-811 Houston SiteHoustonUnited States1
NEO-811 Long Island SiteLake SuccessUnited States1
NEO-811 Los Angeles SiteDuarteUnited States1
NEO-811 NYC SiteNew YorkUnited States1
NEO-811 Omaha SiteOmahaUnited States1
NEO-811 San Diego SiteSan DiegoUnited States1
NEO-811 South Carolina SiteMyrtle BeachUnited States1
NEO-811 Virginia SiteFairfaxUnited States1